Alpha memo: resveratrol exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Explicitly acknowledge and discuss the species difference (rat IL-6/acute-exercise model vs. aged-men training-adaptation RCT) in the alpha sentence and caveats; revise the 'mechanism_to_human_failure' label to reflect cross-species + cross-endpoint comparison.
2. Either narrow the alpha to 'context-dependent signal in resveratrol + exercise literature' (avoiding causal reversal language) or add a third receipt that probes the same endpoint across contexts to justify the reversal claim.
3. Clean the Search receipt line: remove or replace the 'papers_searched' artifact with a real hit count or remove the field.
4. Add a concrete falsifier tied to species and endpoint non-comparability (e.g., 'Reject if endpoints across receipts differ and cannot be aligned to a single construct').
5. Add limitations section addressing: (a) n=2 receipts, (b) cross-species inference, (c) different dosing contexts (resveratrol as antioxidant in rats vs. 250 mg/day in humans), (d) no consensus claim possible.

Major issues

• Receipt 1 is a rat model (Wistar rats) while Receipt 2 is human RCT in aged men; the cross-context 'mechanism_to_human_failure' geometry claim requires explicit acknowledgment that this is a cross-species jump, not just a context difference within humans, which materially affects the interpretation of 'context-dependency.'
• Receipt 1 reports IL-6 responses to acute exercise with resveratrol in rats; Receipt 2 reports that resveratrol blunts exercise-induced cardiovascular/muscular adaptations in aged men. The pair does not measure the same endpoint, making the claim that 'the same anchor can fail, reverse, or split by context' overstated — the two studies probe different mechanisms and outcomes, not the same signal reversing.

Minor issues

• The 'Search receipt' line includes a suspicious token 'papers_searched=1456919317' which looks like an unrendered timestamp rather than a meaningful search statistic; should be cleaned up.
• Caveats/falsifiers list generic rejection criteria but do not flag the species mismatch as the primary falsifier.
• Title of Receipt 1 contains a stray colon artifact ('Exercise.:') suggesting metadata scrubbing hygiene issues.
• The 'Why this is surprising' framing implies contradiction between a rat mechanistic study and a human RCT, but the rat study excerpt actually reports pro-anti-inflammatory effects while the human study shows blunting of training adaptations — these are not direct contradictions of the same outcome, so the 'surprising' framing should be qualified.

Reviewer note

The memo identifies a potentially interesting pattern: a rat study suggesting resveratrol mitigates exercise-induced inflammation versus a human RCT showing resveratrol blunts training adaptations. The two-receipt contrast is real, the citations are grounded in the source bundle, and the alpha-memo format is appropriate. However, the central 'mechanism_to_human_failure' framing overclaims by treating two studies that differ in species (rat vs. human), design (acute inflammation model vs. 8-week training RCT), and endpoint (IL-6/oxidative stress vs. VO2max/training adaptations) as a coherent contextual reversal of 'the same anchor.' The novelty would be proportionate if framed more modestly as a heterogeneity signal in the resveratrol-exercise literature with caveats. Source grounding is adequate (score 4): both receipts exist, are accurately cited, and broadly support the comparative direction, though the deeper integration between species and endpoint is missing. With bounded edits (acknowledging species jump, narrowing the reversal claim, adding explicit limitations), this is salvageable.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis